Teleflex Incorporated (NYSE:TFX) Plans Quarterly Dividend of $0.34

Posted by on Aug 12th, 2026

Teleflex Incorporated (NYSE:TFX – Get Free Report) declared a quarterly dividend on Tuesday, August 4th. Investors of record on Friday, August 14th will be paid a dividend of 0.34 per share by the medical technology company on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, August 14th.

Teleflex has a dividend payout ratio of 9.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect Teleflex to earn $10.63 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 12.8%.

Teleflex Price Performance

TFX stock opened at $133.66 on Wednesday. Teleflex has a one year low of $100.18 and a one year high of $145.00. The firm has a 50-day moving average of $131.99 and a two-hundred day moving average of $123.12. The firm has a market capitalization of $5.66 billion, a PE ratio of -5.74, a P/E/G ratio of 0.88 and a beta of 0.81. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94.

Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The business had revenue of $570.33 million for the quarter, compared to the consensus estimate of $559.59 million. During the same period last year, the firm posted $3.73 earnings per share. The firm’s quarterly revenue was up 28.9% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, analysts forecast that Teleflex will post 7.31 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on TFX shares. UBS Group increased their price objective on Teleflex from $145.00 to $158.00 and gave the stock a “neutral” rating in a research note on Tuesday. Truist Financial boosted their price target on shares of Teleflex from $143.00 to $150.00 and gave the company a “hold” rating in a report on Monday. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. Finally, Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research report on Sunday. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $151.80.

View Our Latest Stock Analysis on Teleflex

About Teleflex

(Get Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Read More

Dividend History for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.